Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Aug. 31, 2025	Aug. 31, 2024
Cash flows from operating activities:
Net income	$ 47,388	$ 67,291
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property and equipment	4,753	4,806
Amortization of acquired intangibles and other	111,081	70,835
Amortization of debt discount and issuance costs	3,064	2,540
Stock-based compensation	47,394	35,011
Non-cash lease expense	8,749	8,898
Deferred income taxes	(12,884)	(14,840)
Credit losses and other sales allowances	3,510	329
Changes in operating assets and liabilities:
Accounts receivable	9,129	25,407
Other assets	4,575	15,090
Accounts payable and accrued liabilities	(15,016)	(6,796)
Lease liabilities	(9,533)	(8,682)
Income taxes payable	1,131	1,341
Deferred revenue, net	(30,952)	(9,387)
Net cash flows from operating activities	172,389	191,843
Net cash flows used in investing activities:
Purchases of property and equipment	(2,840)	(2,328)
Payments for acquisitions, net of cash acquired	(20,653)	0
Net cash flows used in investing activities	(23,493)	(2,328)
Net cash flows used in financing activities:
Proceeds from equity plans	16,040	17,474
Payments for taxes related to net share settlements of equity awards	(10,101)	(10,627)
Repurchases of common stock, including excise tax	(65,108)	(86,777)
Proceeds from issuance of senior convertible notes, net of issuance costs of $11,200	0	438,750
Purchase of capped calls	0	(42,210)
Dividend equivalent and dividend payments to stockholders	(654)	(23,814)
Repayment of revolving line of credit	(110,000)	(110,000)
Principal payment on term loan	0	(261,250)
Payment of credit facility debt issuance costs	(5,961)	(6,821)
Net cash flows used in financing activities	(175,784)	(85,275)
Effect of exchange rate changes on cash and cash equivalents	7,819	1,515
Net (decrease) increase in cash and cash equivalents	(19,069)	105,755
Cash and cash equivalents, beginning of period	118,077	126,958
Cash and cash equivalents, end of period	99,008	232,713
Supplemental disclosure:
Cash paid for income taxes, net of refunds of $1,875 in 2025 and $2,242 in 2024	13,412	15,865
Cash paid for interest	44,202	7,961
Non-cash investing and financing activities:
Total fair value of restricted stock awards, restricted stock units and deferred stock units on date vested	30,075	29,036
Dividends declared and unpaid	0	8,423
Contingent consideration payable in Nuclia acquisition	$ 1,080	$ 0